|
|
A CIRCUITS-FIRST PLATFORM FOR PERSONALIZED NEUROSTIMULATION TREATMENT |
| 1DP1MH116506-01 |
ETKIN, AMIT |
NIMH |
2017 |
|
|
GENOME CLUSTERING FOR CLINICAL SUBTYPE DETECTION IN AUTISM |
| 1F30MH115584-01 |
AMATYA, DEBHA NARSINGH |
NIMH |
2017 |
|
|
FUNCTIONAL SIGNIFICANCE OF STRUCTURAL BRAIN CHANGE DURING COGNITIVE REMEDIATION IN EARLY SCHIZOPHRENIA |
| 1F31MH113277-01A1 |
WOJTALIK, JESSICA |
NIMH |
2017 |
|
|
IMPROVING COMMUNITY MENTAL HEALTH SERVICES FOR ADULTS WITH ASD AND CO-OCCURRING PSYCHIATRIC DISORDERS |
| 1F32MH111166-01A1 |
MADDOX, BRENNA |
NIMH |
2017 |
|
|
MODELING THE NEUROBEHAVIORAL BASIS OF EXTRINSIC AND VOLITIONAL MOTIVATION IN ADHD |
| 1F32MH114608-01 |
HAKIMI, SHABNAM |
NIMH |
2017 |
|
|
STRENGTHENING THE IDENTIFICATION AND TREATMENT OF DEPRESSION IN PRIMARY CARE IN MOZAMBIQUE |
| 1K01MH110599-01A1 |
WAGENAAR, BRADLEY |
NIMH |
2017 |
|
|
STRUCTURAL AND FUNCTIONAL BIOMARKERS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER |
| 1K01MH110645-01A1 |
DOUGLAS, PK |
NIMH |
2017 |
|
|
RISK OF PSYCHOSIS WITH PRESCRIPTION STIMULANT USE |
| 1K23MH110564-01A1 |
MORAN, LAUREN V |
NIMH |
2017 |
|
|
IDENTIFYING THE ROLE OF EMOTION PROCESSES IN CORE FEATURES OF AUTISM SPECTRUM DISORDER |
| 1K23MH115166-01 |
BAL, VANESSA HUS |
NIMH |
2017 |
|
|
ALACRITY FOR LATE- AND MID-LIFE MOOD DISORDERS |
| 1P50MH113838-01 |
ALEXOPOULOS, GEORGE S |
NIMH |
2017 |
